1 year return (CAGR)
153.00%
Fate Therapeutics Inc Exchange (NASDAQ, USD)
FATE
2.53
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
2.35%
5 year return (CAGR)
-47.88%
10 year return (CAGR)
-0.83%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
303.15M
Price/Sales
46.70
Ent value
377.38M
Price/Book
1.98
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-11.42%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.52 |
| Daily high | 2.58 |
| Daily low | 2.44 |
| Daily Volume | 1.27M |
| All-time high | 117.40 |
| 1y analyst estimate | 5.74 |
| Beta | 2.55 |
| EPS (TTM) | -1.05 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| FATE | S&P500 | |
| Current price drop from All-time high | -97.84% | -0.56% |
| Highest price drop | -99.42% | -56.47% |
| Date of highest drop | 3 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -59.38% | -10.68% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 1427 days | 1805 days |
News
